Search research articles
Contact Us
Filters
Showing results (441-450 of 595) with videos related to
Page
of 60
Sort By:
The Biochemical Journal
|
August 9, 2005
Aurora-A site specificity: a study with synthetic peptide substrates
Stefano Ferrari, Oriano Marin, Mario A Pagano, et al.
Blood
|
August 15, 2000
Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites
A M Brunati, L Bordin, G Clari, et al.
Scientific Reports
|
February 18, 2017
Generation and quantitative proteomics analysis of CK2α/α'<sup>(-/-)</sup> cells
Christian Borgo, Cinzia Franchin, Stefano Scalco, et al.
Open Biology
|
February 22, 2023
Analysis of the phosphoproteome of CK2<i>α</i><sup>(-/-)</sup>/Δ<i>α'</i> C2C12 myoblasts compared to the wild-type cells
Christian Borgo, Luca Cesaro, Tsuyoshi Hirota, et al.
Cells
|
January 22, 2021
Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells
Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 19, 2008
Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening
Giorgio Cozza, Alessandra Gianoncelli, Monica Montopoli, et al.
FEBS Letters
|
September 14, 2000
Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2')
O Marin, S Sarno, M Boschetti, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
April 17, 1999
Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity
G Cignarella, D Barlocco, P Vianello, et al.
FEBS Letters
|
August 14, 2003
Functional homology between yeast piD261/Bud32 and human PRPK: both phosphorylate p53 and PRPK partially complements piD261/Bud32 deficiency
Sonia Facchin, Raffaele Lopreiato, Maria Ruzzene, et al.
Leukemia
|
November 4, 2006
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2
S Mishra, V Pertz, B Zhang, et al.
Page
of 60
Search research articles
Search
Showing results (441-450 of 595) with videos related to
Sort By:
Page
of 60
The Biochemical Journal
|
August 9, 2005
Aurora-A site specificity: a study with synthetic peptide substrates
Stefano Ferrari, Oriano Marin, Mario A Pagano, et al.
Blood
|
August 15, 2000
Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites
A M Brunati, L Bordin, G Clari, et al.
Scientific Reports
|
February 18, 2017
Generation and quantitative proteomics analysis of CK2α/α'<sup>(-/-)</sup> cells
Christian Borgo, Cinzia Franchin, Stefano Scalco, et al.
Open Biology
|
February 22, 2023
Analysis of the phosphoproteome of CK2<i>α</i><sup>(-/-)</sup>/Δ<i>α'</i> C2C12 myoblasts compared to the wild-type cells
Christian Borgo, Luca Cesaro, Tsuyoshi Hirota, et al.
Cells
|
January 22, 2021
Contribution of the CK2 Catalytic Isoforms α and α' to the Glycolytic Phenotype of Tumor Cells
Francesca Zonta, Christian Borgo, Camila Paz Quezada Meza, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 19, 2008
Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening
Giorgio Cozza, Alessandra Gianoncelli, Monica Montopoli, et al.
FEBS Letters
|
September 14, 2000
Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2')
O Marin, S Sarno, M Boschetti, et al.
Farmaco (Societa Chimica Italiana : 1989)
|
April 17, 1999
Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity
G Cignarella, D Barlocco, P Vianello, et al.
FEBS Letters
|
August 14, 2003
Functional homology between yeast piD261/Bud32 and human PRPK: both phosphorylate p53 and PRPK partially complements piD261/Bud32 deficiency
Sonia Facchin, Raffaele Lopreiato, Maria Ruzzene, et al.
Leukemia
|
November 4, 2006
Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2
S Mishra, V Pertz, B Zhang, et al.
Page
of 60